AHA Coding Clinic® for ICD-9 - 2008 Issue 4; VOLUMES 1 AND 2 NEW/REVISED CODES
Categories 203-208
Effective October 1, 2008, revisions have been made to the fifth-digit subclassification for the following categories: 203 Multiple myeloma and immunoproliferative neoplasms 204 Lymphoid leukemia 205 Myeloid leukemia 206 Monocytic leukemia 207 Other specified leukemia 208 Leukemia of unspecified type The fifth digit subclassification has been revised as follows: Fifth-digit “0†has been revised to state “without mention of having achieved remission†and to include “failed remission.†Failed remission refers to remission induction therapy where the patient is given a course of chemotherapy...
Subscribe or sign in to view the full article.
Article Overview
This article covers a coding classification update for multiple myeloma and several leukemia categories, with emphasis on a fifth-digit subclassification revision effective October 1, 2008. It is relevant to coders, auditors, and revenue cycle professionals working with hematology and oncology documentation. The article discusses the affected disease categories, the revised status terminology, and the general framework for when the subclassifications apply.
Why This Topic Matters
Accurate classification updates affect diagnosis coding consistency, reporting, and compliance for hematology and oncology claims and records.
Article Sections
-
Effective date and scope of revisions
Introduces the effective date and identifies the diagnosis categories affected by the subclassification update.
-
Revised fifth-digit subclassification guidance
Summarizes the general changes to the fifth-digit structure and the status categories addressed by the update.
-
Category-specific subclassification listings
Presents the affected diagnosis categories and the corresponding revised fifth-digit framework for each one.
What You Will Learn
- Which diagnosis categories are included in the classification update
- What general areas of the fifth-digit subclassification were revised
- How the article organizes the affected hematology categories for reference
- What type of documentation context the update addresses
Who Should Read This
- Medical coders
- Coding auditors
- Revenue cycle staff
- Hematology/oncology documentation specialists
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com